Philippe Busque - 20 May 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 May 2024, 18:28:44 UTC
Prior SEC filing
21 Mar 2024
Next SEC filing
21 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Valerie Barnett, Attorney-in-Fact

Key filing fact

Philippe Busque filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 22 May 2024.

Key facts

  • This page summarizes Philippe Busque's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 22 May 2024, 18:28.

Change

  • Previous filing in this sequence was filed on 21 Mar 2024.
  • Current net transaction value: -$18,881.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,659
Change %
+200%
Price
Shares after
9,994
Date
20 May 2024
Ownership
Direct
Footnotes
F1
CTKB transaction

Common Stock

Tax liability

Transaction value
$15,460
Shares
-2,594
Change %
-26%
Price
$5.96
Shares after
7,400
Date
20 May 2024
Ownership
Direct
Footnotes
F2
CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,473
Change %
+20%
Price
Shares after
8,873
Date
20 May 2024
Ownership
Direct
Footnotes
F1
CTKB transaction

Common Stock

Tax liability

Transaction value
$3,421
Shares
-574
Change %
-6.5%
Price
$5.96
Shares after
8,299
Date
20 May 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-6,659
Change %
-27%
Price
$0.000000
Shares after
17,931
Date
20 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,659
Exercise price
Footnotes
F1, F3
CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-1,473
Change %
-4.2%
Price
$0.000000
Shares after
33,887
Date
20 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,473
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.

Footnote F3

The shares subject to the Restricted Stock Units (the "RSU Award") shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.

Footnote F4

The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .